共 50 条
- [21] InfliximabDevelopment of drug specific antibodies: case report [J]. Reactions Weekly, 2023, 1962 (1) : 224 - 224
- [23] Immunological cross-reactivity of anti-drug antibodies to adalimumab and ABP 501 [J]. JOURNAL OF CROHNS & COLITIS, 2018, 12 : S120 - S120
- [24] InfliximabDevelopment of drug specific antibodies: case report [J]. Reactions Weekly, 2019, 1742 (1) : 126 - 126
- [26] Therapeutic Drug Monitoring of the Biosimilar (AMJEVITA™, Adalimumab-atto) Using Labcorp Adalimumab Assay for Drug Level and Anti-Drug Antibodies [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (12S): : S5 - S6
- [27] Risk factors for the development of anti-drug antibodies to infliximab and adalimumab in Crohn's disease [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S378 - S379
- [28] Immunoassay methods used in clinical studies for the detection of anti-drug antibodies to adalimumab and infliximab [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2018, 192 (03): : 348 - 365
- [29] Anti-drug antibodies to infliximab: A comparison of free anti-drug antibody measurement [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S249 - S250